MBX Biosciences, Inc. Common Stock (MBX) Stock Price

MBXStock

$60.03+341.49%52W

Market Cap$2.89B

P/E—

PEG Ratio—

Div yield—

Beta1.45

MBX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)59.59%

Price vs S&P 500 (4W)-3.73%

VGM Score82.69

MBX Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	-$0.59	-$0.78	-33.18%(-$0.19)
Q1 2026	May 7, 2026	-$0.58	-$0.51	+12.22%(+$0.07)
Q4 2025	Mar 12, 2026	-$0.60	-$0.49	+17.88%(+$0.11)
Q3 2025	Nov 6, 2025	-$0.68	-$0.63	+6.97%(+$0.05)
Q2 2025	Aug 7, 2025	-$0.76	-$0.58	+24.01%(+$0.18)

MBX Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.13

4.27

Industry Peers — Pharmaceuticals(570)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
MBXMBX Biosciences, Inc. Common Stock	—	—	A	—	—	—	—	$60.03
LLYEli Lilly & Co.	D	B	C	14.5x	49.6%	83.4%	27.6%	$1155.29
JNJJohnson & Johnson	D	C	B	6.4x	8.1%	68.0%	14.9%	$265.91
ABBVABBVIE INC.	D	C	B	6.9x	10.4%	72.8%	-2.9%	$257.40
MRKMerck & Co., Inc.	D	C	B	5.0x	4.6%	77.3%	21.2%	$147.74
NVSNovartis AG	C	C	C	4.9x	3.3%	75.0%	15.3%	$152.22
AZNAstraZeneca PLC	C	B	C	4.0x	8.6%	81.3%	21.9%	$162.54
NVONovo-Nordisk A/S	B	C	C	4.0x	5.6%	80.7%	20.7%	$45.41
ABTAbbott Laboratories	C	C	C	4.1x	8.1%	56.8%	8.2%	$110.55
PFEPfizer Inc.	C	D	B	2.4x	-0.2%	74.7%	-3.5%	$28.63
VRTXVertex Pharmaceuticals Inc	D	C	B	10.7x	10.2%	86.0%	8.3%	$543.50
BMYBristol-Myers Squibb Co.	B	B	B	2.7x	3.1%	71.7%	—	$66.74
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	1.5x	39.5%	72.6%	-8.2%	$44.53
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	2.3x	5.0%	73.6%	-0.5%	$50.41
REGNRegeneron Pharmaceuticals Inc	C	C	B	5.3x	9.3%	86.0%	6.3%	$797.73
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	B	1.9x	3.1%	65.5%	-12.6%	$18.00
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	2.5x	4.1%	52.9%	—	$36.05
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	6.8x	36.2%	88.0%	—	$358.32
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	13.2x	10.0%	—	-12.1%	$61.36
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	6.3x	95.1%	79.7%	—	$239.76
ZTSZOETIS INC.	C	C	D	3.2x	1.4%	71.6%	12.0%	$77.03
INSMInsmed, Inc.	F	A	C	25.0x	185.8%	83.5%	—	$120.95
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	3479.3x	-67.6%	81.2%	—	$34.34
UTHRUnited Therapeutics Corp	C	C	B	7.1x	2.5%	86.1%	19.3%	$511.78
GMABGenmab A/S ADS	C	C	B	4.5x	22.3%	93.0%	6.8%	$33.12
VTRSViatris Inc. Common Stock	B	C	B	1.3x	4.4%	40.3%	—	$16.43
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	12.7x	113.3%	91.3%	—	$264.01
JAZZJazz Pharmaceuticals, Inc.	B	C	B	3.5x	12.6%	88.4%	-1.4%	$250.75
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	27.3x	355.2%	95.1%	—	$76.15
BMRNBioMarin Pharmaceuticals Inc	C	C	B	3.9x	11.2%	79.6%	-17.0%	$65.86
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	B	9.1x	149.0%	91.5%	—	$532.49
CORTCorcept Therapeutics Inc.	F	C	B	14.5x	16.0%	98.3%	-0.5%	$112.95
ELANElanco Animal Health Incorporated Common Stock	C	B	C	2.2x	11.9%	55.4%	29.9%	$23.77
ARWRArrowhead Research Corporation	D	A	B	18.2x	16.9%	—	—	$81.30
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	11808.4x	—	—	—	$13.54
AXSMAxsome Therapeutics, Inc	D	B	C	14.6x	56.9%	93.2%	—	$198.87
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	3.0x	-0.9%	61.4%	-15.6%	$12.21
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	10.6x	-7.5%	98.2%	—	$60.28
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	—	—	—	—	$123.96
ABVXAbivax SA American Depositary Shares	—	—	C	—	—	—	—	$111.89
CYTKCytokinetics Inc.	F	D	C	153.0x	-21.1%	—	—	$70.04
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	1202.8x	—	—	—	$342.91
PTGXProtagonist Therapeutics, Inc	F	B	B	35.2x	34.8%	—	—	$145.57
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	212.5x	2928.4%	—	—	$85.00
TGTXTG Therapeutics, Inc.	D	B	B	9.2x	76.1%	82.4%	—	$53.64
ALKSAlkermes Inc. plc	D	C	B	5.0x	10.8%	84.6%	—	$46.80
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	7296.2x	—	—	—	$87.64
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	33.9x	53.5%	70.9%	—	$104.62
BLTEBelite Bio, Inc American Depositary Shares	—	—	C	—	—	—	—	$154.13
TVTXTravere Therapeutics, Inc. Common Stock	F	B	A	9.8x	77.1%	98.6%	—	$65.63
ERASErasca, Inc. Common Stock	—	—	A	—	—	—	—	$17.45

About MBX Biosciences, Inc. Common Stock

MBX Biosciences is a clinical-stage biopharmaceutical company developing precision peptide therapies for endocrine and metabolic disorders. Its proprietary PEP platform optimizes pharmaceutical properties including extended duration, consistent drug exposure, and reduced dosing frequency compared to conventional peptides. The company's pipeline includes three candidates: MBX 2109, MBX 1416, and MBX 4291.